ZA923679B - Diagnostic method - Google Patents
Diagnostic methodInfo
- Publication number
- ZA923679B ZA923679B ZA923679A ZA923679A ZA923679B ZA 923679 B ZA923679 B ZA 923679B ZA 923679 A ZA923679 A ZA 923679A ZA 923679 A ZA923679 A ZA 923679A ZA 923679 B ZA923679 B ZA 923679B
- Authority
- ZA
- South Africa
- Prior art keywords
- serum
- multiple sclerosis
- prosomal
- immunochemical
- diagnostic method
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Rehabilitation Therapy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Detergent Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Lubrication Of Internal Combustion Engines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Electric Propulsion And Braking For Vehicles (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Vehicle Body Suspensions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91401443 | 1991-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA923679B true ZA923679B (en) | 1993-01-27 |
Family
ID=8208577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA923679A ZA923679B (en) | 1991-06-21 | 1992-05-20 | Diagnostic method |
Country Status (13)
Country | Link |
---|---|
US (1) | US5472848A (fr) |
EP (1) | EP0519536B1 (fr) |
JP (1) | JP3225248B2 (fr) |
KR (1) | KR930000951A (fr) |
AT (1) | ATE118893T1 (fr) |
AU (1) | AU656198B2 (fr) |
CA (1) | CA2069546C (fr) |
DE (1) | DE69201463T2 (fr) |
DK (1) | DK0519536T3 (fr) |
ES (1) | ES2072083T3 (fr) |
FI (1) | FI104219B1 (fr) |
IE (1) | IE66243B1 (fr) |
ZA (1) | ZA923679B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030092089A1 (en) * | 2001-11-14 | 2003-05-15 | Moscarello Mario Anthony | Method for diagnosing multiple sclerosis and an assay therefore |
EP1597557A4 (fr) * | 2002-10-11 | 2008-06-11 | Univ California | Methode permettant de diagnostiquer et de pronostiquer la sclerose en plaques |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7807532A (nl) * | 1978-07-13 | 1980-01-15 | Akzo Nv | Metaal-immunotest. |
US4533496A (en) * | 1984-05-08 | 1985-08-06 | Monsanto Company | Method of isolating monoclonal antibodies from hybridoma cultures |
FR2586814A1 (fr) * | 1985-08-30 | 1987-03-06 | Centre Nat Rech Scient | Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules |
US4859612A (en) * | 1987-10-07 | 1989-08-22 | Hygeia Sciences, Inc. | Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite |
JPH01309686A (ja) * | 1988-06-08 | 1989-12-14 | Otsuka Pharmaceut Co Ltd | 多機能プロテアーゼ |
WO1992007269A1 (fr) * | 1990-10-11 | 1992-04-30 | Pro-Soma S.A.R.L. | Procede diagnostique |
-
1992
- 1992-05-20 ZA ZA923679A patent/ZA923679B/xx unknown
- 1992-05-26 EP EP92201491A patent/EP0519536B1/fr not_active Expired - Lifetime
- 1992-05-26 DE DE69201463T patent/DE69201463T2/de not_active Expired - Fee Related
- 1992-05-26 ES ES92201491T patent/ES2072083T3/es not_active Expired - Lifetime
- 1992-05-26 CA CA002069546A patent/CA2069546C/fr not_active Expired - Fee Related
- 1992-05-26 AT AT92201491T patent/ATE118893T1/de not_active IP Right Cessation
- 1992-05-26 DK DK92201491.5T patent/DK0519536T3/da active
- 1992-05-28 JP JP16199692A patent/JP3225248B2/ja not_active Expired - Fee Related
- 1992-05-29 FI FI922480A patent/FI104219B1/fi not_active IP Right Cessation
- 1992-05-30 KR KR1019920009381A patent/KR930000951A/ko not_active Application Discontinuation
- 1992-06-16 AU AU18298/92A patent/AU656198B2/en not_active Ceased
- 1992-07-01 IE IE922001A patent/IE66243B1/en not_active IP Right Cessation
-
1994
- 1994-05-02 US US08/237,966 patent/US5472848A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI104219B (fi) | 1999-11-30 |
ATE118893T1 (de) | 1995-03-15 |
DE69201463D1 (de) | 1995-03-30 |
JP3225248B2 (ja) | 2001-11-05 |
EP0519536A1 (fr) | 1992-12-23 |
FI922480A (fi) | 1992-12-22 |
EP0519536B1 (fr) | 1995-02-22 |
IE922001A1 (en) | 1992-12-30 |
JPH0694707A (ja) | 1994-04-08 |
IE66243B1 (en) | 1995-12-13 |
CA2069546C (fr) | 2005-08-16 |
CA2069546A1 (fr) | 1992-12-22 |
US5472848A (en) | 1995-12-05 |
ES2072083T3 (es) | 1995-07-01 |
DE69201463T2 (de) | 1995-06-14 |
DK0519536T3 (da) | 1995-06-06 |
AU1829892A (en) | 1992-12-24 |
AU656198B2 (en) | 1995-01-27 |
KR930000951A (ko) | 1993-01-16 |
FI922480A0 (fi) | 1992-05-29 |
FI104219B1 (fi) | 1999-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1475125A (en) | Immunological detection | |
DE3265768D1 (en) | A method and a kit for the assay of antibodies to soluble antigens | |
US4092114A (en) | Indirect latex test for determination of immunoglobulins | |
Watanabe et al. | Enzyme immunoassay for human ferritin. | |
GR3005971T3 (fr) | ||
JPS5516290A (en) | Purified antigen for testing against neisseria gonorrhoeae antibody | |
ES520012A0 (es) | Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica. | |
AU2353188A (en) | A diagnostic agent and a method for the determination of apolipoprotein b | |
AU656198B2 (en) | Diagnostic method | |
EP0387027A3 (fr) | Méthodes et réactifs pour le diagnostic de l'endométriose | |
EP0669344A3 (fr) | Anticorps monoclonal et son utilisation dans un essai immunologique. | |
EP0352139A3 (fr) | Détection des antigènes ou anticorps | |
EP0364971A3 (fr) | Procédé pour la détection des antigènes de legionella dans les fluides corporels et similaires, et nécessaire pour sa mise en oeuvre | |
ATE174688T1 (de) | Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes | |
EP0040020A3 (fr) | Enzyme de transcriptase réverse humain, procédé pour sa purification et son application dans la détection du cancer du sein | |
GR940300091T1 (en) | Equipment and test for determining an antigen/antibody in a test sample. | |
EP0141818A1 (fr) | Elimination des caracteristiques d'auto-liaison et de transreactivite au staph a d'un anticorps anti-strep | |
EP0096520A3 (fr) | Détermination d'antigène:Arthrite rhumatique | |
ATE64466T1 (de) | Immuntest. | |
IE881377L (en) | Method for the quantitative determination of serum proteins¹in body fluids and agents for carrying out the process | |
Scherrer | Methods to aid in the diagnosis of multiple sclerosis | |
HUT62705A (en) | Method for detecting illneses by means of blood-serum test | |
IT1226700B (it) | Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo. | |
ES2075803A1 (es) | Procedimiento de la deteccion de neumolisina | |
CA2191061A1 (fr) | Procede de test genetique |